NLRP12 promoted the progression of gastric cancer mainly by promoting the metabolic reprogramming of gastric cancer cells, the expression of histone H3 lysine 18 lactylation (H3K18la) and the stabilization of hexokinase 2 (HK2), a crucial enzyme in glycolysis. The gene discussed is HK2; the disease is gastric cancer.